Skip to main content

Clinical Trials Using Calderasib

Review the clinical trials studying calderasib on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-4 of 4

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
Status: Active
Location: 3 locations
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
Status: Active
Location: 2 locations
A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Status: Active
Location: Lancaster General Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania
A Clinical Study of MK-1084 With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Status: Active
Location: 3 locations